8-KEarnings & ResultsRegulation FDExhibits & Filings

Cencora, Inc. 8-K Report, Financial Results (Jan 23, 2014)

Filed January 23, 2014For Securities:COR

Summary

Cencora, Inc. (formerly AmerisourceBergen Corporation) filed an 8-K on January 23, 2014, reporting on its financial performance for the fiscal quarter ended December 31, 2013. The report highlights the company's earnings and provides updated guidance for fiscal year 2014. Key information for investors includes the reaffirmation of adjusted diluted earnings per share expectations, an increase in revenue growth forecasts, and specific guidance on adjusted operating income growth and margin expectations. The company also provided details on its expected free cash flow generation and capital expenditure plans for fiscal year 2014. Management emphasizes the use of non-GAAP financial measures to provide a more comprehensive view of operating performance, noting that reconciliations to GAAP are available. Investors should pay close attention to the forward-looking statements and guidance provided, as these will be critical for assessing future performance and valuation.

Key Highlights

  • 1Announced fiscal quarter earnings for the period ending December 31, 2013.
  • 2Reaffirmed expected adjusted diluted earnings per share from continuing operations for fiscal year 2014 in the range of $3.60 to $3.73.
  • 3Increased revenue growth expectations for fiscal year 2014 to a range of 30 percent to 34 percent.
  • 4Maintained expectation for adjusted operating income growth in the 12 percent to 16 percent range for fiscal year 2014.
  • 5Expects an adjusted operating margin decline of 20 to 23 basis points in fiscal year 2014, attributed to new business onboarding and growth in high-volume brand pharmaceutical business.
  • 6Continues to expect free cash flow generation between $500 million and $700 million for fiscal year 2014.
  • 7Plans to spend approximately $500 million on share repurchases in fiscal year 2014, subject to market conditions.

Frequently Asked Questions

This 8-K filing serves primarily to report AmerisourceBergen Corporation's (now Cencora, Inc.) financial results for the fiscal quarter ended December 31, 2013, and to provide updated financial guidance for the full fiscal year 2014. It includes a press release with key financial metrics and forward-looking statements.

For fiscal year 2014, the company expects adjusted diluted earnings per share between $3.60 and $3.73, an increased revenue growth rate of 30% to 34%, and adjusted operating income growth of 12% to 16%. While adjusted operating margin is expected to decline by 20 to 23 basis points, the company anticipates generating $500 million to $700 million in free cash flow and plans to repurchase approximately $500 million of its stock.

The expected decline in adjusted operating margin for fiscal year 2014 is attributed to the onboarding of significant new business that carries lower margins, as well as growth in the brand pharmaceutical business with its large customers, which also impacts margin on a percentage basis.

Yes, the company uses non-GAAP financial measures, such as adjusted diluted earnings per share, to evaluate its operating performance. Management believes these non-GAAP measures provide useful supplementary information and facilitate additional analysis for investors, offering a clearer view of underlying operational trends by excluding certain items like gains from antitrust settlements, LIFO expense, acquisition-related costs, and warrant-related impacts.